Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.650
-0.080 (-2.14%)
At close: Mar 13, 2026, 4:00 PM EDT
3.640
-0.010 (-0.27%)
After-hours: Mar 13, 2026, 7:41 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $659.02 million as of March 13, 2026. Its market cap has increased by 113.42% in one year.
Market Cap
659.02M
Enterprise Value
597.76M
1-Year Change
113.42%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $659.02M, a decrease of -59.51%. That is a compound annual growth rate of -23.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 646.34M | 5.21% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 703.84M |
| Alto Neuroscience | 690.60M |
| Jade Biosciences | 683.52M |
| AgomAb Therapeutics NV | 677.93M |
| ProKidney | 673.87M |
| MiMedx Group | 650.72M |
| Zura Bio | 644.20M |
| Tectonic Therapeutic | 640.66M |